Parathyroid carcinoma: A review

Parathyroid carcinoma is a rare entity, comprising fewer than 1% of cases of hyperparathyroidism. The disease generally presents with severe hyperparathyroidism and occasionally with vocal cord paralysis or a firm palpable cervical mass.

[1]  A. Stojadinovic,et al.  Preoperative thyroid ultrasound in all patients undergoing parathyroidectomy? , 2009, The Journal of surgical research.

[2]  Min Jung Kim,et al.  Parathyroid incidentalomas detected on routine ultrasound-directed fine-needle aspiration biopsy in patients referred for thyroid nodules and the role of parathyroid hormone analysis in the samples. , 2009, Thyroid : official journal of the American Thyroid Association.

[3]  M. Kreissl,et al.  New targets and therapeutic approaches for endocrine malignancies. , 2009, Pharmacology & therapeutics.

[4]  D. Tsiftsis,et al.  Parathyroid carcinoma: clinical presentation and management. , 2009, American journal of otolaryngology.

[5]  K. Lee,et al.  Endoscopic Thyroidectomy With the da Vinci Robot System Using the Bilateral Axillary Breast Approach (BABA) Technique: Our Initial Experience , 2009, Surgical laparoscopy, endoscopy & percutaneous techniques.

[6]  B. Wilkins,et al.  Non-Functional Parathyroid Carcinoma: A Review of the Literature and Report of a Case Requiring Extensive Surgery , 2009, Head and neck pathology.

[7]  T. Obara,et al.  Parathyroid Carcinoma: Etiology, Diagnosis, and Treatment , 2009, World Journal of Surgery.

[8]  Q. Duh,et al.  Defining a molecular phenotype for benign and malignant parathyroid tumors , 2009, Cancer.

[9]  L. Wagman,et al.  Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Smallridge,et al.  Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  A. Gill,et al.  Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias , 2006, The American journal of surgical pathology.

[12]  C. Ruffolo,et al.  Results of iterative surgery for persistent and recurrent parathyroid carcinoma , 2005, Langenbeck's Archives of Surgery.

[13]  Brendan C. Stack,et al.  A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003 , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[14]  R. DeLellis.  Parathyroid Carcinoma: An Overview , 2005, Advances in anatomic pathology.

[15]  J. Kasperbauer,et al.  Intraoperative electromyographic monitoring of the recurrent laryngeal nerve in reoperative thyroid and parathyroid surgery. , 2004, Surgery.

[16]  A. Franchi,et al.  Azidothymidine Induces Apoptosis and Inhibits Cell Growth and Telomerase Activity of Human Parathyroid Cancer Cells in Culture , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  Jeffrey E. Lee,et al.  Parathyroid carcinoma: A 22‐year experience , 2004, Head & neck.

[18]  G. Clayman,et al.  Parathyroid carcinoma: Evaluation and interdisciplinary management , 2004, Cancer.

[19]  R. Lloyd,et al.  Parathyroid carcinoma: Is there a role for adjuvant radiation therapy? , 2003, Cancer.

[20]  J. Carpten,et al.  Hyperparathyroidism‐jaw tumour syndrome , 2003, Journal of internal medicine.

[21]  J. Carpten,et al.  HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome , 2002, Nature Genetics.

[22]  Bhuvanesh Singh,et al.  Management of Cancer of the Parathyroid , 2002, Acta oto-laryngologica.

[23]  Q. Duh,et al.  Localization and reoperation results for persistent and recurrent parathyroid carcinoma. , 2001, Archives of surgery.

[24]  E. Shane,et al.  CHAPTER 33 – Parathyroid Carcinoma , 2001 .

[25]  W. Scherbaum,et al.  Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells. , 2000, European journal of endocrinology.

[26]  M. Brandi,et al.  Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma. , 1999, Biochemical and biophysical research communications.

[27]  J. H. Shaw,et al.  Parathyroid cancer: biology and management. , 1999, Surgical oncology.

[28]  I. Fleming,et al.  Two hundred eighty‐six cases of parathyroid carcinoma treated in the U.S. between 1985–1995 , 1999, Cancer.

[29]  M. Vasef,et al.  Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[30]  A. Arnold,et al.  Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. , 1996, The Journal of clinical endocrinology and metabolism.

[31]  P. Subramaniam,et al.  Inactivation of retinoblastoma gene in malignant parathyroid growths: a candidate genetic trigger? , 1995, The Australian and New Zealand journal of surgery.

[32]  S. Furui,et al.  Successful treatment by surgical removal of bone metastasis producing PTH: new approach to the management of metastatic parathyroid carcinoma. , 1994, Internal medicine.

[33]  A. Thor,et al.  Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. , 1994, The New England journal of medicine.

[34]  K. Sandelin,et al.  Histopathological Variables and DNA Cytometry in Parathyroid Carcinoma , 1993, The American journal of surgical pathology.

[35]  J. Carney,et al.  Parathyroid Carcinoma: Clinical and Pathologic Features in 43 Patients , 1992, Medicine.

[36]  M. Silverman,et al.  Parathyroid carcinoma: the Lahey Clinic experience. , 1985, Surgery.

[37]  L. Shaw,et al.  Treatment of hypercalcemia in parathyroid cancer with WR-2721, S-2-(3-aminopropylamino)ethyl-phosphorothioic acid. , 1985, Annals of internal medicine.

[38]  G. Chejfec,et al.  Parathyroid carcinoma: biochemical and pathologic response to DTIC. , 1984, Surgery.

[39]  R. Bukowski,et al.  Successful combination chemotherapy for metastatic parathyroid carcinoma. , 1984, Archives of internal medicine.

[40]  N. Ordóñez,et al.  Parathyroid carcinoma: features and difficulties in diagnosis and management. , 1983, Surgery.

[41]  S. Geller,et al.  Metastatic nonfunctioning parathyroid carcinoma: ultrastructural evidence of secretory granules and response to chemotherapy. , 1981, The American journal of the medical sciences.

[42]  B. Castleman,et al.  Parathyroid carcinoma. A study of 70 cases , 1973, Cancer.

[43]  D. Morton,et al.  Parathyroid Carcinoma: A Collective Review , 1969, Annals of surgery.

[44]  R. Goldin,et al.  Parathyroid carcinoma. A report of two cases and a review of the literature. , 1961, Archives of internal medicine.

[45]  H. Stephenson.  Malignant tumors of the parathyroid glands; a review of the literature with report of a case. , 1950, Archives of surgery.

[46]  F. Harbitz.  On tumors of the Parathyroid Glands. , 1915, The Journal of medical research.

[47]  B. Stack,et al.  Parathyroid carcinoma. , 2010, Otolaryngologic clinics of North America.

[48]  E. Choi,et al.  Endoscopic hemithyroidectomy with prophylactic ipsilateral central neck dissection via an unilateral axillo-breast approach without gas insufflation for unilateral micropapillary thyroid carcinoma: preliminary report , 2009, Surgical Endoscopy.

[49]  Brendan C. Stack,et al.  systematic review of the diagnosis and treatment of primary hyperparathyroidism from to . , 2005 .